Hugh M. Davis serves as Executive at Aclaris Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Hugh M. Davis has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 3, 2026 involved exercising options for 18,675 shares valued at $0.
Hugh M. Davis currently holds 56,025 shares of Aclaris Therapeutics, Inc. (ACRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hugh M. Davis has been a net neutral trader of ACRS stock. They have purchased $0 and sold $0 worth of shares.
Hugh M. Davis's most recent insider trade was on Feb 3, 2026, when they sold 18,675 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 2, 2025 | ACRS | $0 | Option Exercise | 26,750 | $N/A | Discretionary |